
Search SAM.gov-registered contractors by mission sector, compliance posture and contract vehicle.
Search
Live demo
Arclight Demo Aerospace & Defense, Inc.
UEI DEMOPRIMEC01 · CAGE 0DEMO · Prime Corporate
A fictional company, built to show every section filled in.
Open solicitations, teaming requests and recompetes, from SAM.gov and USAspending.
Try an example search
Real filters on live federal data. One click opens the results.
AI capture analysis, capability statement grading and plain-language guides.
Analyze
How TeamingIndex verifies data, protects it and connects to your tools.
Claim your company, free
Verify your UEI with your work email and control how primes see you. Every badge shows who vouches for it and when.
Claim your profileSee TeamingIndex with real data before you sign up: a finished profile and working searches.
Sample pages
Live demo
Arclight Demo Aerospace & Defense, Inc.
UEI DEMOPRIMEC01 · CAGE 0DEMO · Prime Corporate
A fictional company, built to show every section filled in.
Popular
Registration and small-business types: SAM.gov, synced Nov 9, 2026. Compliance: self-attested by the company unless marked verified. The SPRS chip shows a range, never the exact score. How verification works
H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. has not claimed this profile. What you see comes from public SAM.gov and USAspending records; no one from the company has confirmed CMMC, SPRS or clearance details yet. Learn more about CMMC 2.0
UEI and CAGE come from SAM.gov. Other identifiers are listed by the company.
Teaming
Send an introduction and propose a mutual NDA. Their team is notified right away, and you can share the capability statement with your capture team.
No capability narrative yet
No compliance posture published yet
Facility clearance: visible to paid members
Clearance levels are shown only to paying members; TeamingIndex does not advertise clearances (NISPOM 32 CFR 117.9). Learn more about facility clearances · Compare plans
Awards
75N98026P00992
Recompete 6–12 mo: Potential end Jul 12, 2027 (8 months away)NCI - CORRECTIVE EDITING OF SPLICING FACTOR MUTANT MYELODYSPLASTIC SYNDROMES AND CHRONIC MYELOMONOCYTIC LEUKEMIA
Department of Health and Human Services · National Institutes of Health
HHSN268201400003I-HHSN26800003
Completed: Period of performance ended Feb 28, 2026IGF::OT::IGF THE NATIONAL MYELODYSPLASTIC SYNDROMES (MDS) NATURAL HISTORY STUDY, CENTRAL LAB AND BIOREPOSITORY (CLB), TASK ORDER 03,…
Department of Health and Human Services · National Institutes of Health
36C24823N0028
Completed: Period of performance ended Sep 30, 2023PATHOLOGY CONSULTATIONS
Department of Veterans Affairs
75N91021P00898
Completed: Period of performance ended Sep 23, 2022ACQUISITION OF MOFFITT CANCER CENTER SAMPLES FOR A MULTI-ANCESTRY GENOME-WIDE ASSOCIATION STUDY OF LYMPHOID MALIGNANCIES
Department of Health and Human Services · National Institutes of Health
HHSN268201600013I-HHSN26800001
Completed: Period of performance ended Jun 30, 2021IGF::OT::IGF - PRODUCTION ASSISTANCE FOR CELLULAR THERAPIES (PACT)- CELL PROCESSING FACILITIES
Department of Health and Human Services · National Institutes of Health
75N92019F00036
Completed: Period of performance ended Jun 2, 2020IGF::OT::IGF - PRODUCTION ASSISTANCE FOR CELLULAR THERAPIES (PACT)- CELL PROCESSING FACILITIES CELL MANUFACTURING AND PROCESS DEVELOPMENT…
Department of Health and Human Services · National Institutes of Health
75N92019F00005
Completed: Period of performance ended Jun 1, 2020IGF::OT::IGF - PRODUCTION ASSISTANCE FOR CELLULAR THERAPIES (PACT)- CELL PROCESSING FACILITIES CELL MANUFACTURING AND PROCESS DEVELOPMENT…
Department of Health and Human Services · National Institutes of Health
HHSN268201400003I-HHSN26800002
Completed: Period of performance ended Jun 29, 2018IGF::OT::IGF - THE NATIONAL MYELODYSPLASTIC SYNDROMES (MDS) NATURAL HISTORY STUDY- CENTRAL LABORATORY AND BIOREPOSITORY
Department of Health and Human Services · National Institutes of Health
HHSN268201400003I-HHSN26800001
Completed: Period of performance ended Sep 3, 2016IGF::OT::IGF - THE NATIONAL MYELODYSPLASTIC SYNDROMES (MDS) NATURAL HISTORY STUDY- CENTRAL LABORATORY AND BIOREPOSITORY
Department of Health and Human Services · National Institutes of Health
| Award | Agency | NAICS · PSC | Obligated | Period of performance | Recompete |
|---|---|---|---|---|---|
75N98026P00992 NCI - CORRECTIVE EDITING OF SPLICING FACTOR MUTANT MYELODYSPLASTIC SYNDROMES AND CHRONIC MYELOMONOCYTIC LEUKEMIA | Department of Health and Human Services · National Institutes of Health | 541380 · Q301 | $147.8K | Jul 13, 2026 – Jul 12, 2027 | Recompete 6–12 mo: Potential end Jul 12, 2027 (8 months away)AI brief for award 75N98026P00992Bid team |
No contract vehicles on file
No sub-award reports yet
Source: USAspending.gov sub-award reports (FSRS) (opens in a new tab) · sync date not recorded · Prime contractors report first-tier subcontracts of $30,000 or more. Amounts are reported sub-award values.
No SBIR/STTR awards on record
Source: SBIR.gov award records · sync date not recorded
No FedRAMP Marketplace listing
Source: FedRAMP Marketplace · sync date not recorded
Not yet checked against SAM.gov exclusions.
Agencies generally may not award to excluded parties, and primes may not subcontract with them above the threshold in FAR 52.209-6 (except COTS items) without a compelling reason reported to the contracting officer (FAR 9.405, 9.405-2). Some exclusion types apply only to specific programs: read the record on SAM.gov.
No GSA CALC+ rates on record
Source: GSA CALC+ awarded ceiling rates · sync date not recorded
NAICS codes
SAM.gov does not report this entity as small under any listed NAICS code.
Socio-economic status
No socio-economic certifications reported in SAM.gov.
Product & service codes (PSC)
No PSC codes reported.
This company has not published teaming preferences.
No BD contact published
No parent entity reported in SAM.gov.
SBA counts affiliates when it determines whether a business is small (13 CFR 121.103), so a parent’s size can matter for set-aside work.
SAM.gov
Registration, CAGE, NAICS, socio-economic status, corporate hierarchy and exclusions. Last synced Nov 9, 2026.
USAspending.gov
Prime award history and obligations (FPDS), synced nightly.
The contractor
Nothing yet: this profile has not been claimed by the company.
TeamingIndex verification
Credentials marked Verified were checked by a TeamingIndex reviewer; everything else is self-attested.
Corrections
Corrections to SAM.gov data must be made in SAM.gov; TeamingIndex picks them up on the next nightly sync. Go to SAM.gov (opens in a new tab)
Machine-readable: capability.md schema.org JSON-LD embedded in this page.
Zero CUI: TeamingIndex stores verification metadata only, never System Security Plans, POA&Ms or DD Form 254s.
HHSN268201400003I-HHSN26800003 under HHSN268201400003I IGF::OT::IGF THE NATIONAL MYELODYSPLASTIC SYNDROMES (MDS) NATURAL HISTORY STUDY, CENTRAL LAB AND BIOREPOSITORY (CLB), TASK ORDER 03,… | Department of Health and Human Services · National Institutes of Health | 541712 · AN11 | $13M | Aug 30, 2016 – Feb 28, 2026 | Completed: Period of performance ended Feb 28, 2026 |
36C24823N0028 under 36C24819D0005 PATHOLOGY CONSULTATIONS | Department of Veterans Affairs | 621111 · Q515 | $8.6K | Oct 1, 2022 – Sep 30, 2023 | Completed: Period of performance ended Sep 30, 2023 |
75N91021P00898 ACQUISITION OF MOFFITT CANCER CENTER SAMPLES FOR A MULTI-ANCESTRY GENOME-WIDE ASSOCIATION STUDY OF LYMPHOID MALIGNANCIES | Department of Health and Human Services · National Institutes of Health | 541990 · R405 | $42.3K | Sep 24, 2021 – Sep 23, 2022 | Completed: Period of performance ended Sep 23, 2022 |
HHSN268201600013I-HHSN26800001 under HHSN268201600013I IGF::OT::IGF - PRODUCTION ASSISTANCE FOR CELLULAR THERAPIES (PACT)- CELL PROCESSING FACILITIES | Department of Health and Human Services · National Institutes of Health | 541712 · AN12 | $668.3K | Aug 1, 2016 – Jun 30, 2021 | Completed: Period of performance ended Jun 30, 2021 |
75N92019F00036 under HHSN268201600013I IGF::OT::IGF - PRODUCTION ASSISTANCE FOR CELLULAR THERAPIES (PACT)- CELL PROCESSING FACILITIES CELL MANUFACTURING AND PROCESS DEVELOPMENT… | Department of Health and Human Services · National Institutes of Health | 541712 · AN12 | $211.3K | Dec 3, 2018 – Jun 2, 2020 | Completed: Period of performance ended Jun 2, 2020 |
75N92019F00005 under HHSN268201600013I IGF::OT::IGF - PRODUCTION ASSISTANCE FOR CELLULAR THERAPIES (PACT)- CELL PROCESSING FACILITIES CELL MANUFACTURING AND PROCESS DEVELOPMENT… | Department of Health and Human Services · National Institutes of Health | 541712 · AN12 | $525.7K | Oct 31, 2018 – Jun 1, 2020 | Completed: Period of performance ended Jun 1, 2020 |
HHSN268201400003I-HHSN26800002 under HHSN268201400003I IGF::OT::IGF - THE NATIONAL MYELODYSPLASTIC SYNDROMES (MDS) NATURAL HISTORY STUDY- CENTRAL LABORATORY AND BIOREPOSITORY | Department of Health and Human Services · National Institutes of Health | 541712 · AN11 | $1.3M | Sep 1, 2015 – Jun 29, 2018 | Completed: Period of performance ended Jun 29, 2018 |
HHSN268201400003I-HHSN26800001 under HHSN268201400003I IGF::OT::IGF - THE NATIONAL MYELODYSPLASTIC SYNDROMES (MDS) NATURAL HISTORY STUDY- CENTRAL LABORATORY AND BIOREPOSITORY | Department of Health and Human Services · National Institutes of Health | 541712 · AN11 | $928.5K | Sep 4, 2014 – Sep 3, 2016 | Completed: Period of performance ended Sep 3, 2016 |
Source: SAM.gov Exclusions (opens in a new tab) · sync date not recorded
No confirmed match on the Consolidated Screening List (screened Nov 10, 2026).
The list combines Commerce, State and Treasury export-control and sanctions lists. A “no match” result is a name-and-address screen, not an export-compliance determination.
Source: ITA Consolidated Screening List (opens in a new tab) · as of Nov 10, 2026